Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions.
- R. Virmani, F. Kolodgie, A. Burke, A. Farb, S. Schwartz
- BiologyArteriosclerosis, Thrombosis and Vascular Biology
- 1 May 2000
This review will reconsider the current paradigm for understanding the critical, final steps in the progression of atherosclerotic lesions, and devise a simpler classification scheme that is consistent with the AHA categories but is easier to use, able to deal with a wide array of morphological variations, and not overly burdened by mechanistic implications.
Sudden cardiac death.
Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk.
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I.
The term "vulnerable patient" may be more appropriate and is proposed now for the identification of subjects with high likelihood of developing cardiac events in the near future and a quantitative method for cumulative risk assessment of vulnerable patients needs to be developed.
The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents.
Pathological Correlates of Late Drug-Eluting Stent Thrombosis: Strut Coverage as a Marker of Endothelialization
Heterogeneity of healing is a common finding in drug-eluting stents with evidence of LST and demonstrates the importance of incomplete healing of the stented segment in the pathophysiology of L ST.
Computed tomographic angiography characteristics of atherosclerotic plaques subsequently resulting in acute coronary syndrome.
Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the International Working Group for Intravascular Optical…
Pathology of the vulnerable plaque.
- R. Virmani, A. Burke, A. Farb, F. Kolodgie
- Medicine, BiologyJournal of the American College of Cardiology
- 4 October 2007
Thin cap fibroatheromas are common in patients with high total cholesterol (TC) and high TC/high-density lipoprotein cholesterol ratio, in women >50 years, and in those patients with elevated high levels of high sensitivity C-reactive protein.
The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society…
The ultimate intent of this document is to provide an understanding of the range of acceptable approaches for the use of EMB while recognizing that individual patient care decisions depend on factors not well reflected in the published literature, such as local availability of specialized facilities, cardiovascular pathology expertise, and operator experience.